Pathkey.ai Ltd

Research Pathkey.ai Ltd (PKY) on Bullrun: market cap AUD 39.46M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is AUD 39.46M.

About Pathkey.ai Ltd

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations.

Frequently asked questions

What is Pathkey.ai Ltd's market cap?

Pathkey.ai Ltd's market capitalization is AUD 39.46M.

What does Pathkey.ai Ltd do?

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia.